James Solowiej
- Molecular Biology
- Oncology top 10%
- Organic Chemistry top 5%
- Pulmonary and Respiratory Medicine top 10%
- Computational Theory and Mathematics top 5%
- Co-authors
- Brion W. MurrayMichele McTigueRobert S. KaniaJeffrey H. ChenYali DengSimon BergqvistMeirong XuAsako Nagata
- Topics
- Angiogenesis and VEGF in Cancer (3 papers)Chemical Synthesis and Analysis (2 papers)PI3K/AKT/mTOR signaling in cancer (2 papers)
- Cited by
- OncologyOrganic ChemistryToxicology
- Partner nations
- United StatesFrancePoland
In The Last Decade
James Solowiej
9 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Molecular Biology 531
- Oncology 402
- Organic Chemistry 377
- Pulmonary and Respiratory Medicine 280
- Computational Theory and Mathematics 143
Countries citing papers authored by James Solowiej
This map shows the geographic impact of James Solowiej's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Solowiej with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Solowiej more than expected).
Fields of papers citing papers by James Solowiej
This network shows the impact of papers produced by James Solowiej. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Solowiej. The network helps show where James Solowiej may publish in the future.
Co-authorship network of co-authors of James Solowiej
This figure shows the co-authorship network connecting the top 25 collaborators of James Solowiej. A scholar is included among the top collaborators of James Solowiej based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Solowiej. James Solowiej is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Spectrum and Degree of CDK Drug Interactions Predicts Clinical Performancebreakdown → | 307 |
| 2 | 9 | |
| 3 | 197 | |
| 4 | 4 | |
| 5 | Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitorsbreakdown → | 451 |
| 6 | 40 | |
| 7 | 32 | |
| 8 | PF-00337210, a potent, selective and orally bioavailable small molecule inhibitor of VEGFR-2 | 7 |
| 9 | 1 | |
| 10 | 12 |
About James Solowiej
James Solowiej is a scholar working on Molecular Medicine, Oncology and Molecular Biology, having authored 10 papers that have together received 1.1k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (3 papers), Chemical Synthesis and Analysis (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Oncology (402 citations), Organic Chemistry (377 citations) and Toxicology (44 citations). James Solowiej has collaborated with scholars based in United States, France and Poland. Frequent co-authors include Brion W. Murray, Michele McTigue, Robert S. Kania, Jeffrey H. Chen, Yali Deng, Simon Bergqvist, Meirong Xu, Asako Nagata, Wade Diehl and Kevin Ryan. Their work appears in journals such as Proceedings of the National Academy of Sciences, Biochemistry and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.